BSC Member Profiles
Director and Chief Medical Officer, Marion County Public Health Department, Indianapolis, Indiana
Dr. Caine is nationally regarded for her work in public health and infectious diseases, notably in HIV/AIDS prevention and treatment. In addition to her positions at the Marion County Public Health Department, Dr. Caine is a Bicentennial Associate Professor of Medicine in the Indiana University School of Medicine’s Infectious Diseases Division. She is a member of the COVID-19 Task Force of the National Medical Association, an organization where she is a former Chairman of the Board of Trustees and current Chair of the Infectious Diseases Section.
Health Officer and Chief, Communicable Disease Epidemiology and Immunization Section, Public Health – Seattle & King County, Seattle, Washington
Dr. Duchin is a nationally recognized leader in public health, infectious diseases, and epidemiology. His work has spanned a broad range of infectious disease areas, including HIV/AIDS, tuberculosis, zoonotic diseases, bioterrorism preparedness, vaccine safety, and antimicrobial resistance. In addition to serving in the Seattle & King County Health Department, Dr. Duchin is Professor of Medicine at the University of Washington and Adjunct Professor in the university’s School of Public Health. He is a Fellow of the Infectious Diseases Society of America (IDSA) and serves as IDSA’s liaison to CDC’s Advisory Committee on Immunization Practices.
Adjunct Professor, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston
Dr. Le Duc is Adjunct Professor in the Department of Microbiology and Immunology, University of Texas Medical Branch (UTMB). Previously, he was the Director of the Galveston National Laboratory and the John Sealy Distinguished University Chair in Tropical and Emerging Virology. He is a globally respected authority and leader on emerging infections, with particular focus on vector-borne diseases. He has more than four decades of biodefense and public health experience. Before joining UTMB, he served in infectious disease leadership positions at CDC and the World Health Organization, and as a career officer in the U.S. Army Medical Research and Development Command. Dr. Le Duc is a former member of the National Science Advisory Board for Biosecurity and the World Health Organization’s Global Outbreak Alert and Response Network Steering Committee, and he is an active member of the National Academy of Sciences’ Committee on International Security and Arms Control. He is a Fellow of the Infectious Diseases Society of America and a National Associate of the National Research Council of the National Academy of Sciences.
Professor and Chair, Department of Microbiology, Immunology and Molecular Genetics, College of Medicine, University of Kentucky, Lexington
Dr. Messaoudi is Professor and Chair of the Department of Microbiology, Immunology and Molecular Genetics at the University of Kentucky. She has expertise in viral pathogenesis and cellular and innate immunity, with a focus on important human pathogens (primarily viral diseases) in animal models. Previous positions include Assistant Scientist in the Division of Pathobiology and Immunology, Oregon National Primate Research Center; Assistant Professor, Vaccine and Gene Therapy Institute, Oregon Health and Science University; Associate Professor of Biomedical Sciences, School of Medicine, University of California, Riverside; and Professor of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine. Dr. Messaoudi is a member of the American Society for Microbiology and American Association of Immunologists; is a fellow of the American Academy of Microbiology; and serves on the editorial boards of the Journal of Virology, mBio, Frontiers in Microbiology, Scientific Reports, and the Journal of Leukocyte Biology.
Cooley Centennial Professor, Departments of Integrative Biology and Statistics & Data Sciences, The University of Texas, Austin, Texas
At The University of Texas (UT) at Austin, Dr. Meyers was founding Chair of the Department of Statistics and Data Sciences and is founding Director of the UT COVID-19 Modeling Consortium, a national center for pandemic modeling. She also serves as external faculty at the Santa Fe Institute (New Mexico). For more than 20 years, Dr. Meyers has pioneered the application of data-driven models and machine learning to improve the detection, surveillance, forecasting, and control of emerging viral threats, including designing effective disease control strategies for hospitals and metropolitan areas. She is also Associate Editor of the journals Infectious Disease Modeling and Epidemics.
Health Officer, City and County of San Francisco, San Francisco Department of Public Health, San Francisco, California
Dr. Philip also serves as Assistant Clinical Professor in the Division of Infectious Diseases, Department of Medicine, at the University of California, San Francisco. She previously served on the faculty of the California STD/HIV Prevention Training Center in Oakland. She is a member of the Infectious Diseases Society of America; past member of the Board of Directors of the National Coalition of STD Directors; and past member of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment and former Co-Chair of the committee’s STD Workgroup.
Senior Director, Medical Affairs, Public Health Programs, Cepheid, Sunnyvale, California
Dr. Rakeman is a highly regarded public health leader with expertise in immunology and microbiology. At Cepheid, her responsibilities include addressing priorities in the development of tests and technology relevant to pandemic preparedness. Previously, Dr. Rakeman was Assistant Commissioner and Laboratory Director in the New York City Department of Health and Mental Hygiene’s Public Health Laboratory. As a member of the Association of Public Health Laboratories (APHL), she served on APHL’s COVID-19 Task Force in 2020 and 2021 and chaired the Infectious Diseases Committee from 2013 to 2018.
Associate Professor of Medicine, Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City
Dr. Spivak is an Associate Professor of Medicine, Division of Infectious Diseases, and Medical Director of the Antimicrobial Stewardship Programs at University of Utah Health and the Salt Lake City VA. She came to Utah in 2011 after completing residency and fellowship training at the Johns Hopkins University School of Medicine. Her clinical research focuses on evaluating antibiotic prescribing practices and opportunities for improvement, and patient outcomes related to various antibiotic use strategies. She is a member of The Society for Healthcare Epidemiology of America (SHEA), where she serves on the Public Policy and Government Affairs Committee and the Antibiotic Stewardship Committee. She is a Fellow of the Infectious Diseases Society of America (IDSA) and serves as the vice chair of the IDSA Antimicrobial Resistance Committee.
Professor of Pediatrics and Infectious Diseases, Feinberg School of Medicine of Northwestern University
Dr. Tan is an Attending Physician in the Division of Infectious Diseases at the Ann & Robert H. Lurie Children’s Hospital of Chicago. She is also the Medical Director of the hospital’s International Patient Services Program, is Professor of Pediatrics in the Feinberg School of Medicine at Northwestern University, and is Faculty in Pediatric Infectious Diseases at Northwestern Medicine Prentice Women’s Hospital. She is a Fellow of the American Academy of Pediatrics (AAP), a Fellow of the Pediatric Infectious Diseases Society, and a Fellow of the Infectious Diseases Society of America (IDSA). Dr. Tan serves on the Board of Directors, is chair of the Task Force on Inclusion, Diversity, Access and Equity, and is a member of the Education Committee of IDSA. She also serves as a member of the AAP Global Immunization Advocacy Committee and is a Technical Advisor for the AAP/CDC Global Immunization Advocacy Grant. Additionally, she is a member of the Advisory Commission on Childhood Vaccines, U.S. Health Resources and Services Administration, and a member of the Vaccine and Related Biologic Products Advisory Committee of the Center for Biologics Evaluation and Research, Food and Drug Administration.